Curative potential of high-value phytochemicals on COVID-19 infection
- Autores: Sruthi D.1, Dhanalakshmi M.2, Rao H.1, Deepanraj S.3, Jayabaskaran C.1
-
Afiliações:
- Indian Institute of Science
- Bharathiar University
- Tata Institute for Genetics and Society
- Edição: Volume 88, Nº 2 (2023)
- Páginas: 324-334
- Seção: Articles
- URL: https://journals.rcsi.science/0320-9725/article/view/144644
- DOI: https://doi.org/10.31857/S0320972523020112
- EDN: https://elibrary.ru/QHDBLQ
- ID: 144644
Citar
Resumo
Palavras-chave
Sobre autores
D. Sruthi
Indian Institute of Science
Email: sruthi.skylarks@gmail.com
560012 Bengaluru, Karnataka, India
M. Dhanalakshmi
Bharathiar University
Email: sruthi.skylarks@gmail.com
Coimbatore, Tamil Nadu, India
H. Rao
Indian Institute of Science
Email: sruthi.skylarks@gmail.com
560012 Bengaluru, Karnataka, India
Sh. Deepanraj
Tata Institute for Genetics and Society
Email: sruthi.skylarks@gmail.com
560065 Bengaluru, Karnataka, India
C. Jayabaskaran
Indian Institute of Science
Email: sruthi.skylarks@gmail.com
560012 Bengaluru, Karnataka, India
Bibliografia
- Jeon, S. R., Kang, J. W., Ang, L., Lee, H. W., Lee, M. S., Kim, T. H. (2022) Complementary and alternative medicine (CAM) interventions for COVID-19: An overview of systematic reviews, Integr. Med. Res., 11, 1-9, doi: 10.1016/j.imr.2022.100842.
- Oladele, J. O., Ajayi, E. I., Oyeleke, O. M., Oladele, O. T., Olowookere, B. D., Adeniyi, B. M., Oyewole, O. I., and Oladiji, A. T. (2020) A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants, Heliyon, 6, e04897, doi: 10.1016/j.heliyon.2020.e04897.
- Ahmad, S., Zahiruddin, S., Parveen, B., Basist, P., Parveen, A., Gaurav, Parveen, R., and Ahmad, M. (2021) Indian medicinal plants and formulations and their potential against COVID-19 - preclinical and clinical research, Front. Pharmacol., 11, 1-34, doi: 10.3389/fphar.2020.578970.
- Hong-Zhi, D. U., Hou, X. Y., Miao, Y. H., Huang, B. S., and Liu, D. H. (2020) Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP), Chin. J. Nat. Med., 18, 226-230, doi: 10.1016/S1875-5364(20)30022-4.
- Xu, K., Cai, H., Shen, Y., Ni, Q., Chen, Y., Hu, S., Li, J., Wang, H., Yu, L., Huang, H., Qiu, Y., Wei, G., Fang, Q., Zhou, J., Sheng, J., Liang, T., and Li, L. (2020) Management of coronavirus disease-19 (COVID-19): The Zhejiang Experience, J. Zhejiang. Univ. Med. Sci., 49, 147-157, doi: 10.3785/j.issn.1008-9292.2020.02.02.
- Lu, H. (2020) Drug treatment options for the 2019-new coronavirus (2019-nCoV), Biosci. Trends, 14, 69-71, doi: 10.5582/bst.2020.01020.
- Jin, Y. H., Cai, L., Cheng, Z. S., Cheng, H., Deng, T., Fan, Y. P., et al. (2020) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (19-nCoV) infected pneumonia (standard version), Mil. Med. Res., 7, 1-23, doi: 10.1186/s40779-020-0233-6.
- Sruthi, D., and Jayabaskaran, C. (2021) in Biotechnological Approaches to Enhance Plant Secondary Metabolites: Recent Trends and Future Prospects (Shahnawaz, M., ed.) CRC Press, Taylor & Francis, FL., pp. 1-17.
- Ryu, Y. B., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, J. Y., Kim, D., et al. (2010) Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition, Bioorg. Med. Chem., 18, 7940-7947, doi: 10.1016/j.bmc.2010.09.035.
- Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., and Afolabi, S. O. (2021) Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants, J. Biomol. Struct. Dyn., 39, 3396-3408, doi: 10.1080/07391102.2020.1764868.
- Huang, J., Tao, G., Liu, J., Cai, J., Huang, Z., and Chen, J. X. (2020) Current prevention of COVID-19: Natural products and herbal medicine, Front. Pharmacol., 11, 1-18, doi: 10.3389/fphar.2020.588508.
- Benarba, B., and Pandiella, A. (2020) Medicinal plants as sources of active molecules against COVID-19, Front. Pharmacol., 11, 1-16, doi: 10.3389/fphar.2020.01189.
- Park, J. Y., Kim, J. H., Kim, Y. M., Jeong, H. J., Kim, D. W., Park, K. H., et al. (2012) Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases, Bioorg. Med. Chem., 20, 5928-5935, doi: 10.1016/j.bmc.2012.07.038.
- Wu, C. Y., Jan, J. T., Ma, S. H., Kuo, C. J., Juan, H. F., Cheng, Y. S. E., et al. (2004) Small molecules targeting severe acute respiratory syndrome human coronavirus, Proc. Natl. Acad. Sci. USA, 101, 10012-10017, doi: 10.1073/pnas.0403596101.
- Kim, J. W., Ha, T. K. Q., Cho, H., Kim, E., Shim, S. H., and Yang, J. L. (2017) Antiviral escin derivatives from the seeds of Aesculus turbinata Blume (Japanese horse chestnut), Bioorg. Med. Chem. Lett., 27, 3019-3025, doi: 10.1016/j.bmcl.2017.05.022.
- Kumar, V., Dhanjal, J. K., Bhargava, P., Kaul, A., Wang, J., Zhang, H., et al. (2022) Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells, J. Biomol. Struct. Dyn., 40, 1-13, doi: 10.1080/07391102.2020.1775704.
- Weber, C., and Opatz, T. (2019) Bisbenzylisoquinoline Alkaloids, in The Alkaloids: Chemistry and Biology (Knölker, H. J., ed.) Academic Press Inc., pp. 1-249.
- Ruan, Z., Liu, C., Guo, Y., He, Z., Huang, X., Jia, X., et al. (2020) SARS-CoV-2 and SARS-CoV: virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12), J. Med. Virol., 93, 389-400, doi: 10.1002/jmv.26222.
- Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., et al. (2020) Structure of the RNA-dependent RNA polymerase from COVID-19 virus, Science, 368, 779-782, doi: 10.1126/science.abb7498.
- El-Aziz, N. M. A., Shehata, M. G., Awad, O. M. E., and El-Sohaimy, S. A. (2020) Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis, Research Square, doi: 10.21203/RS.3.RS-25850/V1.
- Chen, C. N., Lin, C. P. C., Huang, K. K., Chen, W. C., Hsieh, H. P., Liang, P. H., et al. (2005) Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3′-digallate (TF3), Evid. Based. Complement. Altern. Med., 2, 209-215, doi: 10.1093/ecam/neh081.
- Kim, D. W., Seo, K. H., Curtis-Long, M. J., Oh, K. Y., Oh, J. W., Cho, J. K., et al. (2014) Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia, J. Enzyme. Inhib. Med. Chem., 29, 59-63, doi: 10.3109/14756366.2012.753591.
- Cho, J. K., Curtis-Long, M. J., Lee, K. H., Kim, D. W., Ryu, H. W., Yuk, H. J., et al. (2013) Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa, Bioorg. Med. Chem., 21, 3051-3057, doi: 10.1016/j.bmc.2013.03.027.
- Nguyen, T. T. H., Woo, H. J., Kang, H. K., Nguyen, V. D., Kim, Y. M., Kim, D. W., et al. (2012) Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris, Biotechnol. Lett., 34, 831-838, doi: 10.1007/s10529-011-0845-8.
- Jo, S., Kim, S., Shin, D. H., and Kim, M. S. (2020) Inhibition of SARS-CoV 3CL protease by flavonoids, J. Enzyme. Inhib. Med. Chem., 35, 145-151, doi: 10.1080/14756366.2019.1690480.
- Yu, M. S., Lee, J., Lee, J. M., Kim, Y., Chin, Y. W., Jee, J. G., et al. (2012) Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13, Bioorg. Med. Chem. Lett., 22, 4049-4054, doi: 10.1016/j.bmcl.2012.04.081.
- Park, J. Y., Ko, J. A., Kim, D. W., Kim, Y. M., Kwon, H. J., Jeong, H. J., et al. (2016) Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV, J. Enzyme. Inhib. Med. Chem., 31, 23-30, doi: 10.3109/14756366.2014.1003215.
- Park, J. Y., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, S. J., Kim, D., et al. (2012) Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus, Biol. Pharm. Bull., 35, 2036-2042, doi: 10.1248/bpb.b12-00623.
- Park, J. Y., Kim, J. H., Kwon, J. M., Kwon, H. J., Jeong, H. J., Kim, Y. M., et al. (2013) Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava, Bioorg. Med. Chem., 21, 3730-3737.
- Elfiky, A. A. (2021) Natural products may interfere with SARS-CoV-2 attachment to the host cell, J. Biomol. Struct. Dyn., 39, 3194-3203, doi: 10.1080/07391102.2020.1761881.
- Song, Y. H., Kim, D. W., Curtis-Long, M. J., Yuk, H. J., Wang, Y., Zhuang, N., et al. (2014) Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits, Biol. Pharm. Bull., 37, 1021-1028, doi: 10.1248/bpb.b14-00026.
![](/img/style/loading.gif)